Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs

<< Previous

Bullboard Posts

Next >>

Post by aknahowon Sep 04, 2011 11:42pm

281 Views

Post# 19011653

Minor joint venture with v.evr

Neues Joint Venture mit Everton Resources, um das Projektvoranzubringen•$1,0 Mio. für Bohrungen investiert und neue Zone entdecktBachelor Lake1% NSR (Net Smelter Royalty)• Metanor-Aktivitäten auf der BachelorLake-Liegenschaft inQuebec sollten ab 2012 Royalty-Zahlungen einbringenwww.halores.com HRLN : FSE HLO : TSX.V 21

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments